Alberto Gulino

An integrated approach identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated genes in developing cerebellum and medulloblastoma.

Giuseppe Giannini, L. Di Marcotullio, I. Screpanti, 2008, Neoplasia.

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy

Enzo Di Fabrizio, Ermanno Miele, A. Gulino, 2012, International journal of nanomedicine.

Human MRE11 is inactivated in mismatch repair‐deficient cancers

Alessandra Viel, Fabio Cerignoli, Marco Crescenzi, 2002, EMBO reports.

New pyrrole derivatives with potent tubulin polymerization inhibiting activity as anticancer agents including hedgehog-dependent cancer.

Ettore Novellino, Andrea Brancale, Ruoli Bai, 2014, Journal of medicinal chemistry.

Tissue plasminogen activator is required for corticostriatal long‐term potentiation

Antonio Pisani, Alessandro Martorana, Paolo Calabresi, 2002, The European journal of neuroscience.

Notch3, another Notch in T cell development.

I. Screpanti, D. Bellavia, A. Gulino, 2003, Seminars in immunology.

Hedgehog controls neural stem cells through p53‐independent regulation of Nanog

Mauro Biffoni, M. Biffoni, L. Di Marcotullio, 2010, The EMBO journal.

MiR‐128 up‐regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness

Giuseppe Giannini, C. Dominici, H. McDowell, 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells

Ettore Novellino, Sandro Cosconati, Xing Zhang, 2014, Journal of medicinal chemistry.

Notch3 and the Notch3‐upregulated RNA‐binding protein HuD regulate Ikaros alternative splicing

A. F. Campese, Luigi Frati, I. Screpanti, 2007, The EMBO journal.